BDX Stock: Analysts Predict Mixed Outlook Amid Q3 Earnings Beat
Becton, Dickinson and Company (BDX), a global medical technology giant valued at $50.5 billion by market cap, reported its Q3 results on Aug. 6, with adjusted EPS of $3.23 beating Wall Street expectations of $3.14. The c